Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device
Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device
复制标题
与 Impella 相关的主动脉瓣关闭不全，需要在植入耐用的左心室辅助装置后进行手术干预
DOI：
10.1007/s10047-020-01184-x
复制
发表时间：
2020
影响因子：
1.3
通讯作者：
Murohar
中科院分区：
文献类型：
--
作者：
Oishi Hideo;Kondo Toru;Fujimoto Kazuro;Mutsuga Masato;Morimoto Ryota;Hirano Ken-ichi; Sawamura Akinori;Kazama Shingo;Kimura Yuki;Shibata Naoki;Kato Hiroo;Arao Yoshihito; Kuwayama Tasuku;Yamaguchi Shogo;Hiraiwa Hiroaki;Okumura Takahiro;Usui Akihiko;Murohar
Impella是一种用于心源性休克的轴流式经皮心室辅助装置。在这篇报道中，我们描述了两例与Impella相关的主动脉不全（AI）患者，并在植入耐用左心室辅助装置（LVAD）后需要手术干预。两名患者均出现心源性休克，并接受了Impella 5.0植入作为决定的桥梁。这些患者的心功能没有改善，获得心脏移植批准需要时间。分别用Impella处理91天和98天。在这两种情况下，当移除Impella时，观察到在插入Impella之前不存在的中度AI。因此，我们通过主动脉瓣关闭来控制持久LVAD植入期间的AI。在持久的LVAD植入患者中，AI可能在手术后发生并发展。主动脉瓣手术通常是为了防止AI恶化，尤其是术前AI患者。因此，人工智能作为决策的桥梁，是Impella设备植入后的一个重要并发症。当移除Impella时，必须仔细观察AI，因为在Impella管理过程中，由于设备产生的伪影，通过超声心动图评估AI很麻烦。
The Impella is an axial-flow percutaneous ventricular assist device for cardiogenic shock. In this report, we describe two patients who developed aortic insufficiency (AI) associated with Impella and required surgical intervention upon implantation of the durable left ventricular assist device (LVAD). Both patients presented with cardiogenic shock and underwent insertion of Impella 5.0 as a bridge to decision. The cardiac function in these patients did not improve and obtaining approval for heart transplantation required time. They were managed with Impella for 91 and 98 days, respectively. In both cases, moderate AI that was not present before Impella insertion was observed when the Impella was removed. Therefore, we performed aortic valve closure to control the AI during durable LVAD implantation. In patients with durable LVAD implantation, AI may occur and progress after the operation in several cases. Aortic valve surgery is often performed to prevent deterioration of AI, especially in patients with AI before the surgery. Hence, AI is an important complication following Impella device implantation as a bridge to decision. Careful observation of AI is essential when the Impella is removed as the evaluation of AI by echocardiogram during Impella management is cumbersome because of device-generated artifacts.
登录
查看更多内容
影响因子：
11.3
作者：
Dixon, Simon R.;Henriques, Jose P. S.;O'Neill, William W.
通讯作者：
O'Neill, William W.
DOI：
10.1053/j.jvca.2018.09.035
发表时间：
2019-06-01
影响因子：
2.8
作者：
Hong, Edward;Naseem, Tariq
通讯作者：
Naseem, Tariq
术前 Impella® 支持后植入左心室辅助装置后挽救 TAVI 治疗主动脉瓣反流。
DOI：
--
发表时间：
2017
期刊：
The Journal of heart valve disease
影响因子：
--
作者：
Florian E M Herrmann;P. Wellmann;V. von Dossow;S. Massberg;C. Hagl;R. Schramm;M. Pichlmaier
通讯作者：
M. Pichlmaier
影响因子：
8.9
作者：
Cowger, Jennifer;Rao, Vivek;Estep, Jerry D.
通讯作者：
Estep, Jerry D.
心室辅助装置治疗期间主动脉瓣关闭不全的术前预测。
影响因子：
1.5
作者：
T. Imamura;K. Kinugawa
通讯作者：
K. Kinugawa